Related Experiment Videos

Clinical perspectives of bispecific antibodies in cancer

G C de Gast¹, J G van de Winkel, B E Bast

¹Department of Haematology, University Hospital Utrecht, The Netherlands.

Cancer Immunology, Immunotherapy : CII

|January 22, 1998

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The multifactorial etiology of graft-versus-host disease.

Immunology today·2014

Lack of anti-tumour reactivity despite enhanced numbers of circulating natural killer T cells in two patients with metastatic renal cell carcinoma.

Clinical and experimental immunology·2010

Value of serum S-100B for prediction of distant relapse and survival in stage III B/C melanoma.

Anticancer research·2008

Fc receptor and complement receptor-mediated phagocytosis in host defence.

Current opinion in infectious diseases·2006

Extended continuous oral temozolomide in patients with progressive metastatic renal cell carcinoma not responding to interferon alpha 2b.

Journal of chemotherapy (Florence, Italy)·2006

Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study.

Cancer immunology, immunotherapy : CII·2005

See all related articles